Nerve growth factor (NGF) is essential for the survival of sensory and sympathetic neurons
during development. However, in the adult, NGF and its interaction with tropomyosin …

These updated guidelines present a practical and logical approach to the assessment and
management of acute and chronic pain in canine and feline patients. Recognizing pain is …

Assessment of chronic pain and quality of life (QOL) are integral to clinical veterinary
research and practice, and recent years have seen an increase in the published tools …

The '2022 AAFP/ISFM Cat Friendly Veterinary Interaction Guidelines: Approach and
Handling Techniques'(hereafter the 'Cat Friendly Veterinary Interaction Guidelines') support …

The '2021 AAFP Feline Senior Care Guidelines' are authored by a Task Force of experts in
feline clinical medicine and serve as an update and extension of those published in 2009 …

Background Frunevetmab, a felinized antinerve growth factor monoclonal antibody,
effectively decreases osteoarthritis (OA) pain in cats. Objective To evaluate the efficacy of …

Objectives To identify where a consensus can be reached between veterinary experts in
feline medicine on the core signs sufficient for pain (sufficient to indicate pain when they …

A literature review identified six placebo‐controlled studies of analgesics in client‐owned
cats with degenerative joint disease‐associated pain. Five studies with 96 cats had …

Background Neutralizing antibodies against nerve growth factor (NGF) are analgesic in
rodent models, naturally occurring degenerative joint disease (DJD) pain in dogs, and …

Background Osteoarthritis (OA) is the most commonly diagnosed joint disease in veterinary
medicine, with at least 80% of the cases of lameness and joint diseases in companion …